A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder

Ningdong granule: a complementary and alternative therapy in the treatment of attention deficit/hyperactivity disorder

“…All of the medicines were filled by a pharmacist in charge who mastered the data of treatment assignment and the weight and number of the subjects in the trial. All of the participants were assessed according to the records from their own teachers and parents at different time points by a child psychiatrist using Teacher and Parent ADHD Rating Scale (Dupau 1991;Akhondzadeh et al 2003;Kahbazi et al 2009). The minimum baseline score on the Teacher and Parent ADHD Rating Scale which was required for entry into the study at the start of medication was 20.…”

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial

“…Throughout the study, the person who administrated the medications, the rater, and the patients along with their parents were blind to group assignments. The principal measure of outcome was the Parent and Teacher ADHD-Rating Scale-IV that has been used extensively in Iran in school-age children and provides valid measures of behavioral abnormality and attention (Akhondzadeh et al, 2003(Akhondzadeh et al, , 2004Amiri et al, 2008;Kahbazi et al, 2009;Salehi et al, 2010). ADHD-RS-IV is an instrument that assesses the 18 symptoms of ADHD as defined in the DSM-IV-TR according to a 4-point Likert scale.…”

A Method for Deciding About the Possible Safety of Modafinil and Armodafinil in Patients With Seizure Disorder

“…[22][23][24][25][26][27][28][29] Patients with coarse brain disease are well known to be at increased risk of seizures. However, modafinil has been safely used in these populations, as well; the absence of seizures as an adverse event is especially noteworthy in patients with dementia, 30 head injury, 31,32 and brain tumors.…”